The rationale for adding glucagon receptor agonism is the part that distinguishes it mechanistically
Globally, direct and indirect costs linked to obesity and related sleep disorders reach into the hundreds of billions, reflecting the burden from cardiovascular disease, diabetes, and medical utilization
doi: 10.3389/fimmu.2025.1610368 Received 11 April 2025 Accepted 26 June 2025 Published 15 July 2025 Volume 16 - 2025 Edited by Li-Tung Huang, Kaohsiung Chang Gung Memorial Hospital, Taiwan Reviewed by Beata Kasztelan-Szczerbinska, Medical University of Lublin, Poland Edit Posta, University of Debrecen, Hungary Updates Copyright 2025 Migliorisi, Gabbiadini, Dal Buono, Ferraris, Privitera, Petronio, Bertoli, Bezzio and Armuzzi
The honest framing right now: encouraging, but not yet established for this population
These effects make GLP-1 a powerful tool in managing weight and blood sugar levels, which is why it has become a focal point in the development of medications for diabetes and obesity
The Ultimate No-Bloat Kit for GLP-1 Users Based on research and my experience losing 80 pounds on tirzepatide, here's what I recommend having with you at all times
